Cardinal Health, Inc. (NYSE:CAH) Given Average Rating of “Moderate Buy” by Brokerages

Cardinal Health, Inc. (NYSE:CAH) has earned an average rating of “Moderate Buy” from the eighteen analysts that are presently covering the company, MarketBeat.com reports. Two analysts have rated the stock with a hold recommendation, fifteen have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month price target among brokerages that have covered the stock in the last year is $241.80.

Several research analysts have issued reports on the stock. Jefferies Financial Group raised their price target on shares of Cardinal Health from $220.00 to $270.00 and gave the stock a “buy” rating in a report on Thursday, January 22nd. Barclays boosted their target price on shares of Cardinal Health from $243.00 to $258.00 and gave the company an “overweight” rating in a report on Tuesday, February 24th. Weiss Ratings raised Cardinal Health from a “buy (b)” rating to a “buy (b+)” rating in a research note on Monday, May 4th. JPMorgan Chase & Co. decreased their target price on Cardinal Health from $243.00 to $215.00 and set a “neutral” rating for the company in a research note on Monday, May 4th. Finally, Wells Fargo & Company decreased their target price on Cardinal Health from $256.00 to $245.00 and set an “overweight” rating for the company in a research note on Friday, May 1st.

Cardinal Health Trading Up 2.4%

Shares of CAH opened at $199.90 on Tuesday. The company has a market capitalization of $46.82 billion, a PE ratio of 30.57, a PEG ratio of 1.16 and a beta of 0.53. The stock’s 50-day moving average price is $206.64 and its two-hundred day moving average price is $208.36. Cardinal Health has a 12 month low of $137.75 and a 12 month high of $233.60.

Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.79 by $0.38. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The firm had revenue of $60.94 billion during the quarter, compared to analyst estimates of $62.10 billion. During the same quarter last year, the business earned $2.35 EPS. The company’s revenue was up 11.0% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Equities research analysts predict that Cardinal Health will post 10.76 EPS for the current fiscal year.

Cardinal Health Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be paid a dividend of $0.5158 per share. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. This represents a $2.06 annualized dividend and a yield of 1.0%. The ex-dividend date of this dividend is Wednesday, July 1st. Cardinal Health’s payout ratio is 31.19%.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. Aventura Private Wealth LLC acquired a new position in shares of Cardinal Health during the 4th quarter valued at $25,000. University of Texas Texas AM Investment Management Co. acquired a new stake in shares of Cardinal Health in the 4th quarter valued at about $26,000. Bank of Jackson Hole Trust acquired a new stake in shares of Cardinal Health in the 4th quarter valued at about $27,000. Jones Financial Companies Lllp grew its stake in shares of Cardinal Health by 198.3% in the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after buying an additional 14,034 shares during the period. Finally, Palladiem LLC acquired a new stake in shares of Cardinal Health in the 4th quarter valued at about $28,000. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.